2 weeks Ago By ABMN Staff
Systematic Financial Management LP boosted its holdings in shares of GE HealthCare Technologies Inc. ( NASDAQ:GEHC – Free Report ) by 254.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).
The fund owned 29,432 shares of the company’s stock after purchasing an additional 21,137 shares during the period. Systematic Financial Management LP’s holdings in GE HealthCare Technologies were worth $2,293,000 at the end of the most recent quarter. Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business.
Nemes Rush Group LLC lifted its stake in GE HealthCare Technologies by 110.1% during the second quarter. Nemes Rush Group LLC now owns 500 shares of the company’s stock worth $39,000 after purchasing an additional 262 shares during the last quarter.
Creative Planning lifted its stake in shares of GE HealthCare Technologies by 10.1% in the 2nd quarter. Creative Planning now owns 101,165 shares of the company’s stock valued at $7,883,000 after acquiring an additional 9,273 shares during the last quarter.
Aviso Wealth Management lifted its stake in shares of GE HealthCare Technologies by 41.9% in the 2nd quarter. Aviso Wealth Management now owns 20,582 shares of the company’s stock valued at $1,604,000 after acquiring an additional 6,074 shares during the last quarter.
Texas Capital Bank Wealth Management Services Inc bought a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at $787,000. Finally, Susquehanna Fundamental Investments LLC lifted its stake in shares of GE HealthCare Technologies by 107.1% in the 2nd quarter.
Susquehanna Fundamental Investments LLC now owns 348,703 shares of the company’s stock valued at $27,171,000 after acquiring an additional 180,315 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.
GE HealthCare Technologies Price Performance Shares of NASDAQ GEHC opened at $91.99 on Monday. GE HealthCare Technologies Inc.
has a fifty-two week low of $62.35 and a fifty-two week high of $94.55.
The stock has a market cap of $41.99 billion, a price-to-earnings ratio of 26.90, a PEG ratio of 3.
40 and a beta of 1.17. The company has a debt-to-equity ratio of 1.
05, a quick ratio of 0.82 and a current ratio of 1.06.
The firm’s 50-day simple moving average is $85.13 and its 200 day simple moving average is $83.22.
GE HealthCare Technologies Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $0.03 per share.
The ex-dividend date is Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.
13%. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.
Insiders Place Their Bets In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $80.
78, for a total transaction of $222,145.00. Following the transaction, the chief executive officer now owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.
02. The transaction was disclosed in a legal filing with the SEC, which is available through this link . Insiders own 0.
27% of the company’s stock. Wall Street Analyst Weigh In GEHC has been the subject of a number of research reports. Stifel Nicolaus initiated coverage on GE HealthCare Technologies in a research note on Tuesday, August 6th.
They issued a “buy” rating and a $100.00 price target for the company. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.
00 price objective for the company in a report on Wednesday, September 18th. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. JPMorgan Chase & Co.
initiated coverage on GE HealthCare Technologies in a report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective for the company.
Finally, UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their price objective for the company from $84.00 to $74.00 in a report on Thursday.
One research analyst has rated the stock with a sell rating, five have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $93.
92. Check Out Our Latest Analysis on GE HealthCare Technologies GE HealthCare Technologies Profile ( Free Report ) GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Read More Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. ( NASDAQ:GEHC – Free Report ).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter ..
